Literature DB >> 8699234

Reversion of phenotype of endothelial cells in brain tissue around glioblastomas.

R Vaz1, N Borges, A Sarmento, I Azevedo.   

Abstract

With the aim of studying the putative involvement of peritumoral microvessels in the formation of brain edema, small pieces of peritumoral brain tissue were removed from six patients with glioblastoma multiforme submitted to surgery. All patients had cerebral edema, as shown by preoperative C.T. and N.M.R. Control specimens were obtained from four patients undergoing ventriculo-peritoneal shunt. The tissue fragments were fixed in glutaraldehyde-osmium and embedded in Epon. In semi-thin sections observed under light microscopy peritumoral endothelial cells exhibited voluminous cytoplasm and nucleus. Under the electron microscope, capillary cells from glioblastoma patients differed from controls mainly by showing nuclei rich in euchromatin, cytoplasm rich in pinocytotic vesicles and with occasional fenestrations. All these morphological characteristics are compatible with a process of reversion of phenotype of capillaries around glioblastomas to that of periphery as well as an increase in permeability. Both events may be due to diffusion of a tumoral vascular permeability/endothelial growth factor. This peripheral vessel phenotype of peritumoral microvessels supports their participation in the formation of brain edema and may provide a new clue for therapeutic intervention: for example it fits quite well to the known increase in permeability by leukotrienes and decrease in permeability by corticosteroids in tumoral edema.

Entities:  

Mesh:

Year:  1996        PMID: 8699234     DOI: 10.1007/bf00177475

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  35 in total

1.  Role of leukotrienes as mediator compounds in brain edema.

Authors:  A Unterberg; W Schmidt; M Wahl; A Baethmann
Journal:  Adv Neurol       Date:  1990

2.  Capillary ultrastructure in human metastatic brain tumors.

Authors:  D M Long
Journal:  J Neurosurg       Date:  1979-07       Impact factor: 5.115

Review 3.  Formation and actions of leukotrienes.

Authors:  P J Piper
Journal:  Physiol Rev       Date:  1984-04       Impact factor: 37.312

4.  Ultrastructural changes in blood vessels of perinephritic hypertensive dogs.

Authors:  I Azevedo; J Castro-Tavares; J Garrett
Journal:  Blood Vessels       Date:  1981

5.  Effects of denervation induced by 6-hydroxydopamine on cell nucleus activity of arterial and cardiac cells of the dog.

Authors:  A Sarmento; P Soares-da-Silva; A A Teixeira; I Azevedo
Journal:  J Auton Pharmacol       Date:  1987-06

6.  Permeability characteristics of brain adjacent to tumors in rats.

Authors:  V A Levin; M Freeman-Dove; H D Landahl
Journal:  Arch Neurol       Date:  1975-12

7.  Structural and functional alterations caused at the extraneuronal level by sympathetic denervation of blood vessels.

Authors:  D Branco; A A Teixeira; I Azevedo; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

8.  Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors.

Authors:  S Brem; A M Tsanaclis; S Gately; J L Gross; W F Herblin
Journal:  Cancer       Date:  1992-12-01       Impact factor: 6.860

9.  Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours.

Authors:  V W Li; R D Folkerth; H Watanabe; C Yu; M Rupnick; P Barnes; R M Scott; P M Black; S E Sallan; J Folkman
Journal:  Lancet       Date:  1994-07-09       Impact factor: 79.321

10.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

Authors:  D R Senger; C A Perruzzi; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

View more
  1 in total

1.  Cerebral edema associated with meningiomas: the role of peritumoral brain tissue.

Authors:  R Vaz; N Borges; C Cruz; I Azevedo
Journal:  J Neurooncol       Date:  1998-02       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.